Issue: November 2015
October 01, 2015
1 min read
Save

Vitamin D supplementation increases muscle strength, reduces falls in postmenopausal women

Issue: November 2015
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Postmenopausal women who received vitamin D supplements for 9 months increased their muscle strength, reduced their loss of muscle mass and experienced fewer falls vs. women randomly assigned a placebo, according to recent study findings presented at The North American Menopause Society Annual Meeting.

Luciana M. Cangussu, MSc, of Botucatu Medical School at Sao Paulo State University, Brazil, and colleagues analyzed data from 160 Brazilian women aged 50 to 65 years (mean age, 59 years; average time since menopause, 12 years) with a history of falls during the previous 12 months. Women with osteoporosis or a neurologic, musculoskeletal or vestibular disorder that could affect balance were excluded. In a double blind study, women were randomly assigned 1,000 IU daily vitamin D3 (n = 80) or matching placebo (n = 80) for 9 months. Researchers measured muscle mass with DXA; muscle strength was measured by handgrip strength and a chair-rising test.

At the end of treatment, women in the vitamin D group saw a 25.3% increase in muscle strength by the chair-rising test (P = .036). Women in the placebo group saw a 6.8% loss in muscle mass (P = .03), as well as a 46.3% higher rate of falls (P < .001).

“We concluded that the supplementation of vitamin D alone provided significant protection against the occurrence of sarcopenia, which is a degenerative loss of skeletal muscle,” Cangussu said in a press release. – by Regina Schaffer

Reference:

Cangussu L, et al. P-66. Presented at: The North American Menopause Society Annual Meeting; Sept. 30-Oct. 3, 2015; Las Vegas.

Disclosure: Endocrine Today was unable to confirm any relevant financial disclosures.